Amrize (NYSE:AMRZ) Cut to “Neutral” at JPMorgan Chase & Co.

JPMorgan Chase & Co. downgraded shares of Amrize (NYSE:AMRZFree Report) from an overweight rating to a neutral rating in a research report report published on Wednesday, MarketBeat reports. JPMorgan Chase & Co. currently has $52.00 price objective on the stock, down from their prior price objective of $57.00.

Other equities research analysts also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research note on Friday, June 26th. Weiss Ratings downgraded Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday. Stephens dropped their price objective on Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 12th. William Blair set a $40.00 price objective on Amrize in a research report on Wednesday. Finally, DA Davidson assumed coverage on Amrize in a research note on Monday, August 24th. They set a “neutral” rating and a $50.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $56.38.

View Our Latest Stock Report on AMRZ

Amrize Price Performance

Shares of AMRZ opened at $43.83 on Wednesday. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $48.41 and its 200 day simple moving average is $53.24. Amrize has a 1-year low of $41.61 and a 1-year high of $65.94. The company has a market cap of $24.24 billion, a price-to-earnings ratio of 20.20, a PEG ratio of 1.23 and a beta of 0.04.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). The firm had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. On average, research analysts forecast that Amrize will post 2.72 earnings per share for the current fiscal year.

Amrize Dividend Announcement

The company also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s dividend payout ratio is presently 20.28%.

Insider Activity at Amrize

In other news, CEO Jan Jenisch acquired 26,000 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The shares were purchased at an average cost of $42.47 per share, with a total value of $1,104,220.00. Following the acquisition, the chief executive officer directly owned 1,767,000 shares in the company, valued at $75,044,490. This represents a 1.49% increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Stephen S. Clark acquired 5,260 shares of the stock in a transaction on Tuesday, August 11th. The shares were purchased at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the transaction, the insider directly owned 10,637 shares in the company, valued at approximately $503,236.47. This trade represents a 97.82% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 48,983 shares of company stock valued at $2,158,755 in the last 90 days. Corporate insiders own 0.54% of the company’s stock.

Hedge Funds Weigh In On Amrize

Institutional investors and hedge funds have recently modified their holdings of the business. Caldwell Sutter Capital Inc. raised its stake in Amrize by 11.5% in the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock worth $150,000 after purchasing an additional 275 shares in the last quarter. Rothschild Investment LLC increased its holdings in shares of Amrize by 4.3% during the fourth quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock worth $370,000 after purchasing an additional 280 shares during the period. Baldwin Investment Management LLC increased its holdings in shares of Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock worth $486,000 after purchasing an additional 375 shares during the period. Mengis Capital Management Inc. raised its position in shares of Amrize by 8.5% in the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock valued at $311,000 after buying an additional 450 shares in the last quarter. Finally, Itau Unibanco Holding S.A. raised its position in shares of Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after buying an additional 450 shares in the last quarter.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.